Fax: (770) 488-4639.
1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
Supplement
You have full text access to this OnlineOpen article
Toward using National Cancer Surveillance data for preventing and controlling cervical and other human papillomavirus-associated cancers in the US†‡
Article first published online: 3 NOV 2008
DOI: 10.1002/cncr.23753
Published 2008 by the American Cancer Society
Issue
1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470 "Cancer")
Cancer
Supplement: Assessing the Burden of HPV-Associated Cancers in the United States
Volume 113, Issue Supplement 10, pages 2837–2840, 15 November 2008
Additional Information
How to Cite
Saraiya, M., Ahmed, F., White, M., Lawson, H., Unger, E. R. and Eheman, C. (2008), Toward using National Cancer Surveillance data for preventing and controlling cervical and other human papillomavirus-associated cancers in the US. Cancer, 113: 2837–2840. doi: 10.1002/cncr.23753
- †
Dr. Ahmed was formerly with the Division of Cancer Prevention and Control at the Centers for Disease Control and Prevention, Atlanta, Georgia.The following registries, which cover approximately 83% of the US population, contributed data to the production of this supplement: Alaska, Alabama, Arkansas, California, Colorado, Connecticut, District of Columbia, Delaware, Florida, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, New Jersey, New Mexico, New York, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Texas, Utah, Vermont, Washington, West Virginia, and Wisconsin.We appreciate the in–kind support from all the contributors to this supplement. We are also grateful for the guidance provided by the project steering committee members: Faruque Ahmed, Umed Ajani, Janet Bates, Apputhurai Balamuragan, Vicki Benard, Cheryll Cardinez, Vivien Chen, Glenn Copeland, Michelle Cote, Steve Coughlin, Eileen Dunne, Donatus Ekwueme, Brenda Edwards, Anna Giuliano, Brenda Hernandez, Claudia Hopehayn, Djenaba Joseph, Kris Khan, Jessica King, Sue-Min Lai, Herschel Lawson, Serban Negoita, Marsha Reichman, Tom Richards, Blythe Ryerson, Mona Saraiya, Trevor Thompson, Jasmin Tiro, Meg Watson, Hannah Weir, Mary White, Martin Whiteside, Phyllis Wingo, and Xiao-Cheng Wu. Our gratitude also goes to our team of pathologists, Diane Solomon, Beth Unger, and Mark Sherman; to editorial and graphic services at the Centers for Disease Control and Prevention, especially Fonda Martin, Ernest Martin, and Rick Hull; to Dave Stinchcomb for creating maps; to Jessica King, Trevor Thompson, and Kevin Zhang for the creation of the analytic files and for data verification; to the publication committee (Tom Richards, Mona Saraiya, Phyllis Wingo, and Meg Watson); and to the leadership of the Centers for Disease Control and Prevention's Division of Cancer Prevention and Control for support of this project (Barbara Bowman and Robert German).The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.
- ‡
This article is a US Government work and, as such, is in the public domain in the United States of America.
Publication History
- Issue published online: 3 NOV 2008
- Article first published online: 3 NOV 2008
- Manuscript Accepted: 22 APR 2008
- Manuscript Received: 14 APR 2008
Funded by
- Centers for Disease Control and Prevention
- Cooperative Agreement. Grant Number: U50 DP424071-04
- Centers for Disease Control and Prevention (CDC)
REFERENCES
- 1. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006; 118: 3030–3044.Direct Link:
- 2. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Human Papillomavirus. Lyon, France: International Agency for Research on Cancer; 2007.
- 3,,, et al. Building the infrastructure for nationwide cancer surveillance and control–a comparison between the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) Program (United States). Cancer Causes Control. 2003; 14: 175–193.
- 4Institute of Medicine (IOM) National Research Council and National Cancer Policy Board. Enhancing Data Systems to Improve the Quality of Cancer Care. Washington, DC: The National Academies Press; 2000.
- 5,,, et al. Burden of potentially HPV-associated cancers of the oropharynx and oral cavity in the US, 1998-2003. Cancer. 2008; 113( 10 suppl): 2901–2909Direct Link:
- 6,,, et al. Understanding the burden of HPV-associated anal cancers in the United States. Cancer. 2008; 113( 10 suppl): 2892–2900.Direct Link:
- 7,,, et al. Incidence of in situ and invasive vulvar cancer in the United States, 1998-2003. Cancer. 2008; 113( 10 suppl): 2865–2872.Direct Link:
- 8,,, et al. Descriptive epidemiology of vaginal cancer incidence and survival by race, ethnicity, and age in the United States. Cancer. 2008; 113 ( 10 suppl): 2873–2882.Direct Link:
- 9,,, et al. Burden of penile cancer in the United States. Cancer. 2008; 113( 10 suppl): 2883–2891.Direct Link:
- 10,,, et al. Burden of cervical cancer in the United States, 1998-2003. Cancer. 2008; 113( 10 suppl): 2855–2864.Direct Link:
- 11,,, et al. Using population-based cancer registry data to assess the burden of HPV-associated cancers in the US: overview of methods. Cancer. 2008; 113( 10 suppl): 2841–2854.Direct Link:
- 12,,, et al. Examining the association between socioeconomic factors and human papillomavirus-related cancers. Cancer. 2008; 113( 10 suppl): 2910–2918.Direct Link:
- 13,,. Cervical cancer incidence, mortality, and survival among Asian subgroups in California, 1988-2004. Cancer. 2008; 113( 10 suppl): 2955–2963.Direct Link:
- 14,,,,. Total burden and incidence of in situ and invasive cervical cancer in Michigan, 1985-2003. Cancer. 2008; 113( 10 suppl): 2946–2954.Direct Link:
- 15,,,,. Variability of cervical cancer rates across 5 Appalachian states, 1998-2003. Cancer. 2008; 113( 10 suppl): 2974–2980.Direct Link:
- 16,,, et al. Cervical cancer incidence in the US-Mexico border region, 1998-2003. Cancer. 2008; 113( 10 suppl): 2964–2973.Direct Link:
- 17,,, et al. Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors. Cancer. 2008; 113( 10 suppl): 2919–2925.Direct Link:
- 18,,,. Years of potential life lost and lost productivity costs due to HPV-associated cancer and all malignant cancer mortality in the United States, 2003. Cancer. 2008; 113( 10 suppl): 2936–2945.Direct Link:
- 19,,. Overview of prophylactic HPV vaccines in the United States. Cancer. 2008; 113( 10 suppl): 2995–3003.Direct Link:
- 20,,, et al. HPV and cervical cancer behavioral surveillance in the US. Cancer. 2008; 113( 10 suppl): 3013–3030.Direct Link:
- 21, ,,. Predicting the effect of successful HPV vaccination on existing U.S. cervical screening programs. Cancer. 2008; 113( 10 suppl): 3031–3035.Direct Link:
- 22,,. HPV prophylactic vaccines and the potential prevention of non-cervical cancers in both men and women. Cancer. 2008; 113( 10 suppl): 3036–3046.Direct Link:
- 23,,,,. Cancer registries and monitoring the impact of prophylactic HPV vaccines: potential role. Cancer. 2008; 113( 10 suppl): 3047–3057.Direct Link:
- 24,,, et al. Complementary federal programs for cervical cancer prevention: NBCCEDP, VFC, and 317. Cancer. 2008; 113( 10 suppl): 3004–3012.Direct Link:
- 25,,, et al. A national framework for cancer surveillance in the United States. Cancer Causes Control. 2005; 16: 151–170.